Neurotoxicology 23, 595602
The participants health was tracked every six months, and more than a quarter stopped taking GLP-1s and 23 percent had an interruption of six months or more
Known in peptide research as a copper peptide complex, GHK-Cu remains a recognized compound in studies involving peptide structure, binding behavior, and broader biochemical investigation
Further large-scale, randomised controlled trials with longer follow-up are needed before these medications can be considered an evidence-based treatment option for alcohol use disorder
HDL cholesterol modestly increased across the dose range, while LDL cholesterol showed minimal change a pattern consistent with weight-mediated lipid improvements rather than direct drug effects on LDL pathways
a indicates the map threshold